Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.43 |
| ▸ | HTR3B | O95264 | 2/20 | 0.43 |
| ▸ | HTR3A | P46098 | 2/20 | 0.43 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.43 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11388564 | 1.00 | LMNA (0.52) | LMNACYP2C9TDP1HTR3EHTR3B | |
| Hydrochloric Acid SCHEMBL2417970 | 0.98 | TDP1 (0.52) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL7662681 | 0.82 | LMNA (0.48) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL7662691 | 0.82 | LMNA (0.48) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL7662685 | 0.82 | LMNA (0.48) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL6648506 | 0.81 | LMNA (0.52) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL23475160 | 0.80 | MAPT (0.40) | LMNACYP2C9TDP1MEN1KMT2A | |
| SCHEMBL26728043 | 0.80 | MAPT (0.40) | LMNACYP2C9TDP1MEN1KMT2A | |
| SCHEMBL4128527 | 0.79 | LMNA (0.50) | LMNACYP2C9TDP1HTR3EHTR3B | |
| SCHEMBL16891684 | 0.77 | SMN1; SMN2 (0.39) | LMNATDP1CHRM3CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-20220362160-A1 | ABUSE RESISTANT CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-11-17 | — | — | US | claimed |
| US-11464747-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-10-11 | — | — | US | claimed |
| US-20250345767-A1 | METHODS AND DEVICES FOR GENERATING CORE-SHELL DROPLETS AND PARTICLES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-11-13 | — | — | US | disclosed |
| EP-3824878-B1 | ABUSE RESISTANT CAPSULE | SCHERER TECHNOLOGIES LLC R P (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | disclosed |
| US-20240108726-A1 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | ACURA PHARMACEUTICALS, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| US-11857629-B2 | Methods and compositions for self-regulated release of active pharmaceutical ingredient | ACURA PHARMACEUTICALS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-20230390210-A1 | MODIFIED RELEASE SOFTGEL CAPSULES | R.P. SCHERER TECHNOLOGIES, LLC | 2023-12-07 | — | — | US | disclosed |
| US-20230372252-A1 | CONTROLLED RELEASE FILL COMPOSITIONS AND CAPSULES CONTAINING SAME | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230330044-A1 | METHODS AND COMPOSITIONS FOR INTERFERING WITH EXTRACTION OR CONVERSION OF A DRUG SUSCEPTIBLE TO ABUSE | ACURA PHARMACEUTICALS INC (US) | 2023-10-19 | — | — | US | disclosed |
| WO-2014085599-A1 | SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | ACURA PHARMACEUTICALS, INC. (US) | 2014-06-05 | — | — | WO | disclosed |
| WO-2013025425-A1 | SOLUBLE GUANYLATE CYCLASE ACTIVATORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-02-21 | — | — | WO | disclosed |
| CN-101027044-A | Oral dosage form safeguarded against abuse | GRUENENTHAL GMBH (DE) | 2007-08-29 | — | — | CN | disclosed |
| US-5561149-A | FOR NASAL ADMINISTRATION | SANDOZ LTD. (CH) | 1996-10-01 | — | — | US | disclosed |
| US-4281130-A | Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate | STERLING DRUG INC. (US) | 1981-07-28 | — | — | US | disclosed |
| US-4233448-A | 3-Methoxycarbonyl-2-(2-thienyl)-8-azabicyclo[3.2.1]octane-8-acetamide and salts thereof | STERLING DRUG INC. (US) | 1980-11-11 | — | — | US | disclosed |
| US-4233449-A | 1-(8-Methyl-2-phenyl(or thienyl)-8-azabicyclo[3.2.1]octan-3-yl) ethanone | STERLING DRUG INC. (US) | 1980-11-11 | — | — | US | disclosed |
| US-4214084-A | Ethanopyrrolo[1,2-b]isoquinolines | STERLING DRUG INC. (US) | 1980-07-22 | — | — | US | disclosed |
| US-4179567-A | 2-Aryltropane compounds | STERLING DRUG INC. (US) | 1979-12-18 | — | — | US | disclosed |